Notes
incremental cost-effectiveness ratio
Reference
Laprise JF, et al. COMPARING 2- AND 3-DOSE 9-VALENT HPV VACCINE SCHEDULES IN THE U.S.: A COST-EFFECTIVENESS ANALYSIS. Journal of Infectious Diseases : 27 May 2016. Available from: URL: http://dx.doi.org/10.1093/infdis/jiw227
Rights and permissions
About this article
Cite this article
Cost savings with two doses of 9-valent HPV vaccine. PharmacoEcon Outcomes News 755, 18 (2016). https://doi.org/10.1007/s40274-016-3125-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3125-y